Yellow fever vaccine booster doses: Recommendations of the advisory committee on immunization practices, 2015

Morbidity and Mortality Weekly Report

Volumn 64, Issue 23, 2015, Pages 647-650

  Erin Staples, J ^a   Bocchini, Joseph A ^b,c   Rubin, Lorry ^b,d   Fischer, Marc ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Advisory Committee on Immunization Practices ^*  (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

ADVISORY COMMITTEE; CHILD; FEMALE; HEALTH; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; PRACTICE GUIDELINE; PREGNANCY; PRESCHOOL CHILD; RISK ASSESSMENT; STANDARDS; TRAVEL; UNITED STATES; VACCINATION; YELLOW FEVER;

ADVISORY COMMITTEES; CHILD; CHILD, PRESCHOOL; FEMALE; GLOBAL HEALTH; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RISK ASSESSMENT; TRAVEL; UNITED STATES; VACCINATION; YELLOW FEVER; YELLOW FEVER VACCINE;

EID: 84931838781     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. CDC. Advisory Committee on Immunization Practices (ACIP): summary report, February 26, 2015. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. Available at http://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
2. Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ; ACIP Evidence Based Recommendations Work Group (EBRWG). Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine 2011;29:9171–6.
3. CDC. GRADE evidence tables–recommendations in MMWR. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. Available at http://www.cdc.gov/vaccines/acip/recs/GRADE/table-refs.html.
4. World Health Organization, Division of Epidemiological Surveillance and Health Situation Trend Assessment. Global health situation and projections—estimates. Geneva, Switzerland: World Health Organization; 1992.
5. Monath T, Gershman MD, Staples JE, Barrett AD. Yellow fever vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Sixth ed. London, England: W.B. Saunders; 2013.
6. Monath TP, Cetron MS. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 2002;34:1369–78.
7. Staples JE, Gershman M, Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59(No. RR-7).
8. World Health Organization. International Health Regulations. Second ed. Geneva, Switzerland: World Health Organization; 2005. Available at http://whqlibdoc.who.int/publications/2008/9789241580410_eng.pdf.
9. World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper—June 2013. Wkly Epidemiol Rec 2013;88:269–83.
10. Gotuzzo E, Yactayo S, Córdova E. Efficacy and duration of immunity following yellow fever vaccination: systematic review on the need for a booster every 10 years. Am J Trop Med Hyg 2013;89:434–44.
11. World Health Organization. International travel and health: world– yellow fever vaccination booster, June 5, 2014. Geneva, Switzerland: World Health Organization; 2014. Available at http://www.who.int/ ith/updates/20140605/en.
12. Nasidi A, Monath TP, Vandenberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 1993;87:337–9.
13. Suzano CE, Amaral E, Sato HK, Papaiordanou PM; Campinas Group on Yellow Fever Immunization during pregnancy. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine 2006;24:1421–6.
14. Ljungman P, Lewensohn-Fuchs I, Hammarström V, et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994;84:657–63.
15. Rubin LG, Levin MJ, Ljungman P, et al.; Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58:e44–100.
16. Veit O, Niedrig M, Chapuis-Taillard C, et al.; Swiss HIV Cohort Study. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis 2009;48:659–66.
17. Sibailly TS, Wiktor SZ, Tsai TF, et al. Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1997;16:1177–9.
18. Veit O, Hatz C, Niedrig M, Furrer H. Yellow fever vaccination in HIV-infected patients. HIV Ther 2010;4:17–26.